Clinical Trials in New York State

Showing 2741-2760 of 8,190 trials

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

NCT05629494

Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United States annually and elevated prostate-specific antigen (PSA) level is the primary reason for prostate biopsy in \> 90% of cases. However, at the PSA levels which trigger prostate biopsy, often no cancer is found in prostate biopsy specimens. PSA test can be elevated due to reasons other than cancer such as inflammation or natural variation in the level. Investigators plan to treat men with elevated PSA level with over the counter anti-inflammatory medications (ibuprofen, naproxen) to see if the PSA level will decrease to an acceptable level.

Prostate CancerProstate InflammationPSA

Albany Medical College198 participantsStarted Sep 2022

Chicago, Illinois, United States • Albany, New York, United States • Hershey, Pennsylvania, United States

COMPLETEDNA70 miles

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

NCT05817045

This is a randomized, double-blind, sham controlled, stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID-19 in the at-home setting.

COVID-19

EmitBio Inc.330 participantsStarted Apr 2023

Mesa, Arizona, United States • Phoenix, Arizona, United States • Anaheim, California, United States +45 more locations

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Find Trials by Condition in New York State

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Stockholm3 Validation Study in a Multi-Ethnic Cohort

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms